Research Design Service: West Midlands
« back

Versus Arthritis: Accelerating New Treatments Versus Arthritis

  Wednesday, 01 Dec 2021 | Funding Deadline

As part of the UK Musculoskeletal Translational Research Collaboration (MSK TRC), Versus Arthritis are launching the second call for research projects focused on mechanistic experimental/translational medicine studies in humans across the areas of prevention, diagnosis or treatment that are aimed at priming the next transitional step.

The MSK TRC is a partnership between Versus Arthritis and the National Institute for Health Research. The partnership aims for the globally recognised centres of the UK to be at the forefront of musculoskeletal experimental medicine. The collaboration draws on the rich discovery, clinical and translational research landscape of the UK to accelerate new treatments and deliver cutting edge improvements for patients. Applications should be focused on an unmet need, within or across the UK MSK TRC’s themes. Studies can employ novel design, exploratory endpoints, biomarkers, imaging, big data or profiling/stratification approaches.


Deadline for proposals: 01 December 2021

Find out more here